Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market
Holding RLAY?
Track your performance easily

Relay Therapeutics (RLAY) Income Statement

386 Followers

Relay Therapeutics Income Statement

Last quarter (Q2 2024), Relay Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q2, Relay Therapeutics's net income was $-92.21M. See Relay Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 35.21M$ 25.55M$ 1.38M$ 3.03M$ 82.65M$ 0.00
Cost of Revenue
------
Gross Profit
$ 35.21M$ 25.55M$ 1.38M$ 3.03M--
Operating Expense
$ 392.10M$ 404.97M$ 300.66M$ 355.87M$ 138.45M$ 84.05M
Operating Income
$ -356.89M$ -373.00M$ -299.27M$ -352.84M$ -55.80M$ -84.05M
Net Non Operating Interest Income Expense
$ 34.04M$ 31.05M$ 8.79M$ -11.03M$ 3.40M$ 8.80M
Other Income Expense
$ -687.00K$ 6.40M$ -2.35M$ 2.84M$ -16.00K$ -58.00K
Pretax Income
$ -340.73M$ -341.97M$ -302.17M$ -363.87M$ -52.41M$ -75.31M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -325.23M$ -341.97M$ -302.17M$ -363.87M$ -230.20M$ -75.31M
Basic EPS
$ -2.52$ -2.79$ -2.59$ -3.82$ -5.40$ -1.15
Diluted EPS
$ -2.52$ -2.79$ -2.59$ -3.82$ -5.40$ -1.15
Basic Average Shares
$ 510.97M$ 122.58M$ 112.23M$ 95.14M$ 42.62M$ 65.43M
Diluted Average Shares
$ 510.97M$ 122.58M$ 112.23M$ 95.14M$ 42.62M$ 65.43M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 203.58M$ 404.97M$ 300.66M$ 355.87M$ 138.45M$ 84.05M
Net Income From Continuing And Discontinued Operation
$ -322.83M$ -341.97M$ -290.51M$ -363.87M$ -52.41M$ -75.31M
Normalized Income
$ -157.57M-$ -250.39M-$ -52.41M$ -75.31M
Interest Expense
------
EBIT
$ -252.54M$ -379.42M$ -302.17M$ -352.84M$ -55.80M$ -84.05M
EBITDA
$ -247.63M$ -374.15M$ -296.88M$ -346.89M$ -52.25M$ -81.20M
Currency in USD

Relay Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis